Cargando…

Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model

Endemic human coronaviruses (HCoVs) have been evidenced to be cross-reactive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although a correlation exists between the immunological memory to HCoVs and coronavirus disease 2019 (COVID-19) severity, there is little experimental evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Ahn Young, Lee, Pureum, Lee, Moo-Seung, Kim, Doo-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2023
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166660/ https://www.ncbi.nlm.nih.gov/pubmed/37179748 http://dx.doi.org/10.4110/in.2023.23.e19

Ejemplares similares

Pre-Existing Population Immunity and severe acute respiratory syndrome coronavirus 2 Variant Establishment and Dominance Dynamics in the United States: An Ecological Study
por: Ankomah, Pierre O, et al.
Publicado: (2022)

Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
por: Tang, Xin-Zi Emily, et al.
Publicado: (2022)

Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease
por: Simpson, Megan, et al.
Publicado: (2020)

Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity
por: Zeng, Qiang, et al.
Publicado: (2020)

Pre-existing immunity to covid-19 hints at universal coronavirus vaccine
por: Le Page, Michael
Publicado: (2021)

Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19
por: Lee, Pureum, et al.
Publicado: (2020)

Pan-coronavirus epitope buried in spike
por: Hofer, Ursula
Publicado: (2022)

Blast from the past for coronavirus immunity
por: Hofer, Ursula
Publicado: (2021)

Insights into coronavirus immunity taught by the murine coronavirus
por: Grabherr, Sarah, et al.
Publicado: (2021)

‘Prime and spike’ induces mucosal immunity and reduces SARS-CoV-2 transmission
por: Flemming, Alexandra
Publicado: (2022)

Does Herd Immunity Exist in Aquatic Animals?
por: Standish, Isaac F., et al.
Publicado: (2016)

Responses of mice to murine coronavirus immunization
por: Smith, A. L., et al.
Publicado: (1992)

Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
por: Leng, Qibin, et al.
Publicado: (2020)

Milder disease with Omicron: is it the virus or the pre-existing immunity?
por: Sigal, Alex
Publicado: (2022)

Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals
por: Mahajan, Swapnil, et al.
Publicado: (2021)

Piglet immunization with a spike subunit vaccine enhances disease by porcine epidemic diarrhea virus
por: Yu, Jieshi, et al.
Publicado: (2021)

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
por: Henze, Larissa, et al.
Publicado: (2023)

A Fusion Peptide in the Spike Protein of MERS Coronavirus
por: Alsaadi, Entedar A. J., et al.
Publicado: (2019)

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia
por: Lee, Eun-Ju, et al.
Publicado: (2021)

Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity
por: Abela, Irene A., et al.
Publicado: (2021)

Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients
por: Pandey, Manoj Kumar
Publicado: (2022)

Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
por: Shim, Byoung-Shik, et al.
Publicado: (2010)

Pre-existing immunity against vaccine vectors – friend or foe?
por: Saxena, Manvendra, et al.
Publicado: (2013)

Strategy to detect pre-existing immunity to AAV gene therapy
por: Falese, L, et al.
Publicado: (2017)

Pre-existing immunity modulates responses to mRNA boosters
por: Dangi, Tanushree, et al.
Publicado: (2022)

Pre-existing immunity modulates responses to mRNA boosters
por: Dangi, Tanushree, et al.
Publicado: (2023)

Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
por: Maeda, Osamu
Publicado: (2023)

Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine
por: Yang, Jinyoung, et al.
Publicado: (2023)

Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus
por: Ding, Jun, et al.
Publicado: (2022)

DNA Methyltransferase 3b in Myeloid Cells Does Not Affect the Acute Immune Response in the Airways during Pseudomonas Pneumonia
por: Qin, Wanhai, et al.
Publicado: (2022)

Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
por: Smit, Wouter L., et al.
Publicado: (2022)

AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
por: Li, Ang, et al.
Publicado: (2020)

Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020
por: de Oliveira-Filho, Edmilson F., et al.
Publicado: (2022)

COVID-19 mortality is associated with pre-existing impaired innate immunity in health conditions
por: Lee, Matthew, et al.
Publicado: (2022)

Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity
por: Wang, F.-I., et al.
Publicado: (1992)

Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
por: Hauser, Blake M., et al.
Publicado: (2022)

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity
por: Roy, Sreeja, et al.
Publicado: (2020)

Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence
por: Phillips, Joanna J., et al.
Publicado: (2001)

Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
por: Ricca, Jacob M., et al.
Publicado: (2018)

Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1n43k4h22b5bqv3ni0hgi7kdg1